Trump Administration Drops Plan to Curb Drug Rebates
The Trump administration is dropping a plan to curb billions of dollars in annual rebates that drugmakers give middlemen in Medicare, a proposal it had said would drive down the prices consumers pay for prescription drugs.
The decision reflects months of tension between the White House and the Department of Health and Human Services over the proposal, which also spurred a backlash from pharmacy-benefit managers that administer prescription-drug programs. It was a centerpiece of President Trump’s blueprint to lower drug costs.
The plan had been to curtail the rebates worked...